Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€69.30
21.01.21
-
21.01.22
17.39%
29.06.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.13
11.01.21
€50.00
11.01.22
-5.37%
29.01.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Medtronic plc

Start price
Target price
Perf. (%)
€97.71
10.01.21
-
10.01.22
-2.05%
11.01.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.22
04.01.21
€75.00
04.01.22
11.33%
05.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.29
21.12.20
€42.00
-3.06%
01.02.21

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Nanostr.technol.

Start price
Target price
Perf. (%)
€57.50
13.12.20
-
13.12.21
-41.91%
14.12.21

Risky Investment
iRhythm Technologies Inc

Start price
Target price
Perf. (%)
€151.00
02.12.20
-
02.12.21
-42.05%
03.12.21

Risky Investment
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.10
30.11.20
€14.00
30.11.21
-7.21%
14.12.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.50
30.11.20
€15.00
30.11.21
31.85%
14.12.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€21.00
30.11.20
€25.00
30.11.21
-15.71%
14.12.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
30.11.20
€7.00
30.11.21
-
14.12.20

Could be very worthwhile Investment >20% year
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.50
16.11.20
€13.00
16.11.21
-3.48%
30.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.20
16.11.20
€15.00
16.11.21
2.27%
30.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€18.10
16.11.20
€20.00
16.11.21
16.02%
30.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
16.11.20
€7.00
16.11.21
-
30.11.20

Could be very worthwhile Investment >20% year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.97
12.11.20
€50.00
12.11.21
21.49%
13.07.21

Top 10 in its market
Small cyclical dependencies
Below average Management
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€9.55
02.11.20
€11.00
04.11.21
4.19%
16.11.20

Could be worthwhile Investment >10% per year